MO Stock Surges 13% With A 6-day Winning Spree On UBS Upgrade To Buy
Altria (MO) – a manufacturer and seller of smokeable and oral tobacco products – hit 6-day winning streak, with cumulative gains over this period amounting to a 13%. The company market cap has surged by about $12 Bil over the last 6 days, and currently stands at $104 Bil.
The stock has YTD (year-to-date) return of 6.8% compared to 1.4% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity, or a trap.
What Triggered The Rally?
[1] UBS Upgrade to ‘Buy’
- Rating raised from ‘neutral’ to ‘buy’
- Price objective increased to $63.00
- Impact: Shift in investor sentiment, Increased institutional buying
Opportunity or Trap?
Below is our take on valuation.
There are a few things to fear in MO stock given its overall Moderate operating performance and financial condition. Considering stock’s Low valuation we think it is Attractive (For details, see Buy or Sell MO).
But here is the real interesting point.
You are reading about this 13% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that haven not surged yet.
Returns vs S&P 500
The following table summarizes the return for MO stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | MO | S&P 500 |
|---|---|---|
| 1D | 0.2% | 0.3% |
| 6D (Current Streak) | 12.5% | 0.3% |
| 1M (21D) | 6.1% | 1.9% |
| 3M (63D) | -3.3% | 4.1% |
| YTD 2026 | 6.8% | 1.4% |
| 2025 | 18.2% | 16.4% |
| 2024 | 40.8% | 23.3% |
| 2023 | -3.7% | 24.2% |
However, big gains can follow sharp reversals – but how has MO behaved after prior drops? See MO Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 113 S&P constituents with 3 days or more of consecutive gains and 47 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 32 | 20 |
| 4D | 38 | 14 |
| 5D | 5 | 7 |
| 6D | 34 | 5 |
| 7D or more | 4 | 1 |
| Total >=3 D | 113 | 47 |
Key Financials for Altria (MO)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $20.5 Bil | $20.4 Bil |
| Operating Income | $11.5 Bil | $11.6 Bil |
| Net Income | $8.1 Bil | $11.3 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $4.5 Bil | $5.3 Bil |
| Operating Income | $2.7 Bil | $3.2 Bil |
| Net Income | $1.1 Bil | $2.4 Bil |
While MO stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.